Krystal Biotech

KRYS NASDAQ
44.30
+0.29
+0.66%
交易中 10:30 08/21 EDT
开盘
44.47
昨收
44.01
最高
44.89
最低
43.68
成交量
1.89万
成交均量(3M)
22.78万
52周最高
51.67
52周最低
14.30
换手率
0.11%
市值
7.66亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Krystal Biotech KRYS股票价格,Krystal Biotech股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Krystal Biotech, Inc. is a gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Company's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Company's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness and dehydration.
展开 >

最近浏览

名称
价格
涨跌幅